China SXT Pharmaceuticals (SXTC) Shares Outstanding (Diluted) (2018 - 2026)
China SXT Pharmaceuticals (SXTC) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 833.33 Mn |
| 10 | China SXT Pharmaceuticals | 30,840.48 | -28.15 Mn | - | 8,496.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 679,648.00 |
| Sep 30, 2025 | 773,905.00 |
| Mar 31, 2025 | 9,493.00 |
| Sep 30, 2024 | 21,553.00 |
| Mar 31, 2024 | 723.00 |
| Sep 30, 2023 | 418.00 |
| Mar 31, 2023 | 223.00 |
| Sep 30, 2022 | 85.00 |
| Mar 31, 2022 | 35.00 |
| Sep 30, 2021 | 26.00 |
| Mar 31, 2021 | 24.00 |
| Sep 30, 2020 | 22.00 |
| Mar 31, 2020 | 9.00 |
| Sep 30, 2019 | 9.00 |
| Mar 31, 2019 | 9.00 |
| Sep 30, 2018 | 8.00 |
| Mar 31, 2018 | 8.00 |